Literature DB >> 29340924

Impact of Preoperative Opioid Use After Emergency General Surgery.

Young Kim1, Alexander R Cortez1, Koffi Wima1, Vikrom K Dhar1, Krishna P Athota1, Jason J Schrager1, Timothy A Pritts1, Michael J Edwards1, Shimul A Shah2,3.   

Abstract

BACKGROUND: Preoperative exposure to narcotics has recently been associated with poor outcomes after elective major surgery, but little is known as to how preoperative opioid use impacts outcomes after common, emergency general surgical procedures (EGS).
METHODS: A high-volume, single-center analysis was performed on patients who underwent EGS from 2012 to 2013. EGS was defined as the seven emergent operations that account for 80% of the national burden. Preoperative opioid use was defined as having an active opioid prescription within 7 days prior to surgery. Chronic opioid use was defined as having an opioid prescription concurrent with 90 days after discharge.
RESULTS: A total of 377 patients underwent EGS during the study period. Preoperative opioid use was present in 84 patients (22.3%). Preoperative opioid users had longer hospital LOS (10.5 vs 6 days), higher costs of care ($25,331 vs $11,454), and higher 30-day readmission rates (22.6 vs 8.2%) compared with opioid-naïve patients (p < 0.001 each). After covariate adjustment, preoperative opioid use was predictive of LOS (RR 1.19 [1.01-1.41]) and 30-day hospital readmission (OR 2.69 [1.25-5.75]) (p < 0.05 each). Total direct cost was not different after modeling. Preoperative opioid users required more narcotic refills compared with opioid-naïve patients (5 vs 0 refills, p < 0.001). After discharge, 15.4% of opioid-naïve patients met criteria for chronic opioid use, vs 77.4% in preoperative opioid users (p < 0.001).
CONCLUSIONS: Preoperative opioid use is associated with greater resource utilization after emergency general surgery, as well as vastly different postoperative opioid prescription patterns. These findings may help to inform the impact of preoperative opioid use on patient care, and its implications on hospital and societal cost.

Entities:  

Keywords:  Emergency general surgery; Narcotics; Opioids; Outcomes

Mesh:

Substances:

Year:  2018        PMID: 29340924     DOI: 10.1007/s11605-017-3665-x

Source DB:  PubMed          Journal:  J Gastrointest Surg        ISSN: 1091-255X            Impact factor:   3.452


  18 in total

1.  Chronic pre-operative opioid use and acute pain after fast-track total knee arthroplasty.

Authors:  E K Aasvang; T H Lunn; T B Hansen; P W Kristensen; S Solgaard; H Kehlet
Journal:  Acta Anaesthesiol Scand       Date:  2015-12-28       Impact factor: 2.105

2.  Ambulatory diagnosis and treatment of nonmalignant pain in the United States, 2000-2010.

Authors:  Matthew Daubresse; Hsien-Yen Chang; Yuping Yu; Shilpa Viswanathan; Nilay D Shah; Randall S Stafford; Stefan P Kruszewski; G Caleb Alexander
Journal:  Med Care       Date:  2013-10       Impact factor: 2.983

3.  The perioperative effects of chronic preoperative opioid use on shoulder arthroplasty outcomes.

Authors:  Jonathan W Cheah; David C Sing; Dell McLaughlin; Brian T Feeley; C Benjamin Ma; Alan L Zhang
Journal:  J Shoulder Elbow Surg       Date:  2017-07-20       Impact factor: 3.019

4.  Preoperative Opioid Use is a Predictor of Poor Return to Work in Workers' Compensation Patients After Lumbar Diskectomy.

Authors:  Jeffrey A O'Donnell; Joshua T Anderson; Arnold R Haas; Rick Percy; Stephen T Woods; Uri M Ahn; Nicholas U Ahn
Journal:  Spine (Phila Pa 1976)       Date:  2018-04-15       Impact factor: 3.468

5.  Trends in use of opioids for chronic noncancer pain among individuals with mental health and substance use disorders: the TROUP study.

Authors:  Mark J Edlund; Bradley C Martin; Andrea Devries; Ming-Yu Fan; Jennifer Brennan Braden; Mark D Sullivan
Journal:  Clin J Pain       Date:  2010-01       Impact factor: 3.442

6.  Preoperative Opioid Misuse is Associated With Increased Morbidity and Mortality After Elective Orthopaedic Surgery.

Authors:  Mariano E Menendez; David Ring; Brian T Bateman
Journal:  Clin Orthop Relat Res       Date:  2015-02-19       Impact factor: 4.176

7.  Preoperative opioid use and its association with perioperative opioid demand and postoperative opioid independence in patients undergoing spine surgery.

Authors:  Sheyan J Armaghani; Dennis S Lee; Jesse E Bible; Kristin R Archer; David N Shau; Harrison Kay; Chi Zhang; Matthew J McGirt; Clinton J Devin
Journal:  Spine (Phila Pa 1976)       Date:  2014-12-01       Impact factor: 3.468

8.  Preoperative opioid use associated with worse outcomes after anatomic shoulder arthroplasty.

Authors:  Brent J Morris; Aaron D Sciascia; Cale A Jacobs; T Bradley Edwards
Journal:  J Shoulder Elbow Surg       Date:  2015-12-02       Impact factor: 3.019

9.  Preoperative Opioid Use is Independently Associated With Increased Costs and Worse Outcomes After Major Abdominal Surgery.

Authors:  David C Cron; Michael J Englesbe; Christian J Bolton; Melvin T Joseph; Kristen L Carrier; Stephanie E Moser; Jennifer F Waljee; Paul E Hilliard; Sachin Kheterpal; Chad M Brummett
Journal:  Ann Surg       Date:  2017-04       Impact factor: 12.969

Review 10.  Opioid therapy for chronic pain in the United States: promises and perils.

Authors:  Mark D Sullivan; Catherine Q Howe
Journal:  Pain       Date:  2013-09-11       Impact factor: 6.961

View more
  3 in total

Review 1.  The prescription opioid crisis: role of the anaesthesiologist in reducing opioid use and misuse.

Authors:  Ellen M Soffin; Bradley H Lee; Kanupriya K Kumar; Christopher L Wu
Journal:  Br J Anaesth       Date:  2018-12-28       Impact factor: 9.166

2.  Preoperative Opioid Use and Readmissions Following Surgery.

Authors:  Ruiqi Tang; Katherine B Santosa; Joceline V Vu; Lewei A Lin; Yen-Ling Lai; Michael J Englesbe; Chad M Brummett; Jennifer F Waljee
Journal:  Ann Surg       Date:  2022-01-01       Impact factor: 12.969

3.  Classifying Preoperative Opioid Use for Surgical Care.

Authors:  Joceline V Vu; David C Cron; Jay S Lee; Vidhya Gunaseelan; Pooja Lagisetty; Matthew Wixson; Michael J Englesbe; Chad M Brummett; Jennifer F Waljee
Journal:  Ann Surg       Date:  2020-06       Impact factor: 13.787

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.